By Amanda Bronstad | July 26, 2022
Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.
By Colleen Murphy | July 26, 2022
The New Jersey Appellate Division upheld a jury's verdict of $1.8 million and a judge's award of $1.5 million in attorney fees for a former Novartis employee fired after blowing the whistle on the purchase of a report from one of the company's distributors that she believed constituted a kickback.
By Trudy Knockless | July 20, 2022
Matthew Orlando, who has been with Johnson and Johnson more than 15 years, is taking the legal reins of the consumer health business, which generates about $15 billion in revenue annually.
By Jessica Mach | July 18, 2022
The change in leadership comes a year after attorneys general from several states announced a $26 billion settlement to resolve thousands of opioid lawsuits against a company subsidiary and three other firms.
By Charles Toutant | July 14, 2022
Since the District of New Jersey enacted a local rule in June 2021 mandating the disclosure of any third-party litigation funding arrangements, many such arrangements have come to light in high-profile mass tort suits in New Jersey, said Anthony Anastasio, president of the New Jersey Civil Justice Institute.
By Amanda Bronstad | June 2, 2022
Plaintiffs lawyers at Baum, Hedlund, Aristei & Goldman filed a motion to coordinate more than 30 lawsuits over Merck's Gardasil vaccine but said there could be more, citing 39 claims that went through the Vaccine Court claims process and 52 others that are pending. Michael Baum, of Baum Hedlund, called Merck's criticism a "false straw man argument."
By Colleen Murphy | May 26, 2022
The U.S. Court of Appeals for the Third Circuit ruled against a pair of pharmaceutical distributors in their constitutional claim against two private entities, finding that while the harm may be real, the claims missed a key element: a state actor.
By Charles Toutant | May 10, 2022
Since those suits were dismissed, additional information has been uncovered by plaintiffs in talc injury suits, including dozens of reports on Johnson & Johnson's talc-containing products showing the presence of asbestos and internal communications regarding development of a strategy to discredit reports showing asbestos in J&J products, the suit said.
By Charles Toutant | May 6, 2022
"Since each case registered in the Olmesartan settlement program had a common liability as well as specific facts that supported a unique damage award, such cases, including Martino's and those of the putative class of plaintiffs here, cannot ground allegations that give rise to the applicability of Rule 1:21-7(i)," Senior U.S. District Judge Robert Kugler wrote.
New Jersey Law Journal | Analysis
By James J. DeCarlo and Jose R. Vento | April 29, 2022
Be mindful of this decision when drafting patent applications. Merely mentioning a claim element once may be an insufficient written description if it is not clear that the inventor was in "possession" of the claimed subject matter.
Presented by BigVoodoo
New Jersey Law Journal honors lawyers leaving a mark on the legal community in New Jersey with their dedication to the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
McCarter & English, LLP, a well established and growing law firm, is actively seeking a talented and driven associate having 2-5 years o...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS